title: [Intravitreal application of triamcinolone--our experiences].
abstract: OBJECTIVE
  To show the results of intravitreal application of triamcinolone used as a primary or adjuvant therapy.
  
  
  METHODS
  We analyzed 48 patients with different ocular disorders: exudative age related macular degeneration, diabetic retinopathy, or central retinal vein occlusion. We analyzed color fundus photography, visual acuity, fluorescein angiography and complications of intravitreal triamcinolone application.
  
  
  RESULTS
  There was a marked reduction of macular edema in 70% of patients verified on fluorescein angiography. Visual acuity improved in 62% of patients. The most common complication was transient rise in intraocular pressure. There was no case of endophthalmitis.
  
  
  CONCLUSIONS
  Intravitreal application of triamcinolone is relatively safe and efficacious in selected patiens with different ocular disorders.
authors.affiliation: Klinika za ocne bolesti, Klinicka bolnica Sestre milosrdnice, Zagreb, Hrvatska.
authors.forename: Slavica
authors.initials: S
authors.lastname: Konjević Pernar
authors.forename: Zoran
authors.initials: Z
authors.lastname: Vatavuk
authors.forename: Goran
authors.initials: G
authors.lastname: Bencić
authors.forename: Ante
authors.initials: A
authors.lastname: Pentz
authors.forename: Zdravko
authors.initials: Z
authors.lastname: Mandić
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014822:Vitreous Body
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide